Proactive headlines: Jubilee Metals, Faron Pharmaceuticals, Redx Pharma…
A look at some of the main headlines from the Proactive newswire
Jubilee Metals Group PLC (LON:JLP) said it entered into long-term PGM (platinum group metals) feed supply agreement with a chrome mining customer, signalling Jubilee s PGM expansion into the Eastern Limb of the Bushveld Complex in South Africa.
Faron Pharmaceuticals Oy (LON:FARN, First North:FARON) said research has been published supporting the immunotherapeutic blockade of Clever-1 to activate anti-tumour immune responses in advanced cancer patients.
Redx Pharma PLC (AIM:REDX) said its second wholly-owned molecule has now entered the clinic. Candidate RXC007, which is being developed to treat fibrosis, will be administered to healthy volunteers to assess its safety and tolerability and also the way it interacts with the body.